Infectious Arthritis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Infectious Arthritis

View Main Condition: Arthritis

What is the definition of Infectious Arthritis?
Infectious arthritis is joint pain, soreness, stiffness and swelling caused by a bacterial, viral, or fungal infection that spreads from another part of the body. Depending on the type of infection, one or more joints may be affected. Certain bacteria can cause a form of Infectious arthritis called reactive arthritis, which appears to be caused by the immune system reacting to bacteria, rather than by the infection itself. In reactive arthritis, joint inflammation develops weeks, months or even years after the infection. Reactive arthritis happens most commonly after infections of the genital and gastrointestinal tracts. To diagnose Infectious arthritis, your health care provider may do tests of your blood, urine, and joint fluid.
What are the alternative names for Infectious Arthritis?
  • Infectious arthritis
  • Septic arthritis
Who are the top Infectious Arthritis Local Doctors?
Elite in Infectious Arthritis
Elite in Infectious Arthritis
Referral may be required

Texas Scottish Rite Hospital For Children

2222 Welborn St, 
Dallas, TX 
Languages Spoken:
English
Accepting New Patients

Lawson Copley is an Orthopedics provider practicing medicine in Dallas, Texas. Dr. Copley is rated as an Elite provider by MediFind in the treatment of Infectious Arthritis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Infectious Arthritis, Pyomyositis, Septic Arthritis, and Toxic Synovitis. Dr. Copley is board certified in Orthopaedic Surgery- American Board Of Orthopaedic Surgery. Dr. Copley is currently accepting new patients.

Elite in Infectious Arthritis
Elite in Infectious Arthritis
Referral may be required

CHU Gabriel Montpied

Clermont-ferrand, FR 

Daniel Wendling practices practicing medicine in Clermont-ferrand, France. Mr. Wendling is rated as an Elite expert by MediFind in the treatment of Infectious Arthritis. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Arthritis, Ankylosing Spondylitis, Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Osteotomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Infectious Arthritis
Elite in Infectious Arthritis
Referral may be required
Toronto, ON, CA 

Robert Inman practices practicing medicine in Toronto, Canada. Mr. Inman is rated as an Elite expert by MediFind in the treatment of Infectious Arthritis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Arthritis, and Reactive Arthritis.

What are the latest Infectious Arthritis Clinical Trials?
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Summary: Differentiating between septic arthritis and other causes of joint inflammation in pediatric patients is challenging and of the utmost importance because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard to diagnose septic arthritis in children is a positive synovial fluid culture; however, joint cultures may take several days to return. If ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Comparing Optimal Step-down Therapy for Children With Invasive MRSA Trimethoprim-Sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

Summary: The goal of this clinical trial is to learn if trimethoprim-sulfamethoxazole (TMP-SMX) works to treat invasive infections due to methicillin-resistant Staphylococcus aureus (MRSA) in children. It will also learn about the safety of TMP-SMX in the treatment of children with invasive MRSA infections. The main questions it aims to answer are: -Is TMP-SMX effective at successfully treating children wi...

Who are the sources who wrote this article ?

Published Date: May 13, 2022
Published By: Genetic and Rare Diseases Informnation Center